NCT07187102

Brief Summary

Aim of the work :

  1. 1.To detect if there is any change would occur in the neovascularity and echogenicity after using cervical and upper thoracic SNAG or not in ME patients.
  2. 2.To find the effect of cervical and upper thoracic SNAG on pain, function of upper extremities, grip strength in ME comparing with traditional treatment alone

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 8, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2026

Completed
Last Updated

March 30, 2026

Status Verified

September 1, 2025

Enrollment Period

7 months

First QC Date

September 15, 2025

Last Update Submit

March 25, 2026

Conditions

Keywords

MobilizationMedial EpicondylitisUltrasonographySNAGsPRTEEDASHsympathetic activity

Outcome Measures

Primary Outcomes (1)

  • Colour Ultrasonography

    Change in hypervascularity and hypoechogencity measured by colour sonography ( grade 1: grade 4) include: hypo-echoic variations within the common flexor tendon, tendon sheath thickening, ruptures of varying thickness, neovascularization as seen by Doppler, and cortical damage at the medial epicondyle

    Baseline and after one month

Secondary Outcomes (4)

  • The Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire

    Baseline and after one month

  • A Patient-Rated Elbow Evaluation (PREE) questionnaire.

    Baseline and after one month

  • The hydraulic hand dynamometer.

    Baseline and after one month

  • Visual analog scale

    Baseline and after one month

Study Arms (2)

Experimental group

EXPERIMENTAL
Other: SNAG ( sustained natural apopheseal glide )Other: (Conventional Physical Therapy)

control group

OTHER
Other: (Conventional Physical Therapy)

Interventions

A postero-anterior glide was applied to the spinous process of the C6-7 cervical. Ten repetitions were held for 10 seconds each, followed by a 30-second rest period. The patient sat comfortably with their back resting on a straight seat and their head and neck in a relaxed neutral position. After identifying the hypomobile segment, the clinician administered a single sub-therapeutic dose of thoracic SNAG at the specified treatment level. This technique involved performing one thoracic SNAG with a cephalad glide, applied parallel to the facet joint plane, aiming towards the patient's eyes. The clinician then positioned one arm around the patient's chest, just above the designated treatment level, ensuring that the ulnar border of the mobilizing hand was placed over the thoracic spinous process of the targeted level. Over four weeks, each patient had three therapy sessions per week, with a maximum of 12 sessions total.

Experimental group

Conventional treatment, includes five sets of 30-second self-wrist flexor stretching; a total of 5 minutes of ultrasound therapy at a frequency of 3.3 MHz and a duty cycle of 1.2 W/cm²; five minutes of cross-friction massage focused on the most painful area; and fifteen minutes of heat application. Over four weeks, each patient had three therapy sessions per week, with a maximum of 12 sessions total.

Experimental groupcontrol group

Eligibility Criteria

Age35 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranges from 35 to 50 years old in both sexes.
  • Patients with LE that diagnosed by orthopedist.
  • Pain onset is more than 3 months appear primarily with use or rest or in both, also , it appear with deep palpation of the medial epicondyle .

You may not qualify if:

  • Rheumatoid Arthritis .
  • Skin infection.
  • History of previous elbow surgery.
  • Any pathology in the shoulder joint.
  • Neurologic deficit in upper extremity.
  • Cervical disc prolapse and radiculopathy C5,6.
  • Dislocation of elbow joint.
  • Recent fractures of upper extremity.
  • Arthrosis of the radiohumeral joint.
  • Osteochondritis dissecans.
  • Osteonecrosis.
  • Plica synovialis.
  • Participants receiving other treatment, in the form of physical therapy or medication, for the duration of the study that may interfere with the results of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Beni-Suef University

Banī Suwayf, Egypt

Location

MeSH Terms

Conditions

Elbow Tendinopathy

Condition Hierarchy (Ancestors)

TendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
the participants ( patients) have been masked
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: one group receive SNAG plus traditional treatment second group receive traditional treatment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of physical therapy for musculoskeletal disorders and its surgery , beni suef university

Study Record Dates

First Submitted

September 15, 2025

First Posted

September 22, 2025

Study Start

September 8, 2025

Primary Completion

March 25, 2026

Study Completion

March 25, 2026

Last Updated

March 30, 2026

Record last verified: 2025-09

Locations